Health care companies by P/S ratio
Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.
Roivant Sciences leads the 154 health care companies ranked by P/S ratio, at 3397, ahead of Dianthus Therapeutics (2323) and CG Oncology (1769). Figures as of 19 Nov 2026, 10:03 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 154
- First
- Roivant Sciences3397
- Median
- 4.3
- Combined market value
- TRY 458.96T
- Countries
- 14
- Not ranked
- 16no P/S ratio on file
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | P/S ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Roivant SciencesROIV · Health Care | 3397 | TRY 1.42T | TRY 1,954.40 | 0.05% up | 90% up | ||
| 2 | Dianthus TherapeuticsDNTH · Health Care | 2323 | TRY 238.6B | TRY 4,237.82 | 3.45% down | 113% up | ||
| 3 | CG OncologyCGON · Health Care | 1769 | TRY 360.6B | TRY 4,036.98 | 1.34% up | 85% up | ||
| 4 | CRISPR TherapeuticsCRSP · Health Care | 1111 | TRY 196.7B | TRY 2,028.08 | 0.10% up | 21% down | ||
| 5 | Kymera TherapeuticsKYMR · Health Care | 264 | TRY 521.8B | TRY 6,112.50 | 0.32% down | 87% up | ||
| 6 | Protagonist TherapeuticsPTGX · Health Care | 180 | TRY 418.8B | TRY 6,416.79 | 2.00% up | 46% up | ||
| 7 | CytokineticsCYTK · Health Care | 81.2 | TRY 360.8B | TRY 2,589.73 | 0.64% down | 20% down | ||
| 8 | ImmunityBioIBRX · Health Care | 62.9 | TRY 359.7B | TRY 338.10 | 7.03% up | 193% up | ||
| 9 | Rhythm PharmaceuticalsRYTM · Health Care | 43.5 | TRY 416.5B | TRY 6,007.03 | 2.08% up | 13% up | ||
| 10 | InsmedINSM · Health Care | 43.3 | TRY 1.33T | TRY 6,045.38 | 1.69% down | 40% down | ||
| 11 | ModernaMRNA · Health Care | 41.0 | TRY 4.02T | TRY 9,930.48 | 4.84% down | 755% up | ||
| 12 | GRAILGRAL · Health Care | 31.2 | TRY 231.7B | TRY 5,152.20 | 3.57% down | 20% up | ||
| 13 | BridgeBio PharmaBBIO · Health Care | 30.3 | TRY 766.8B | TRY 3,936.56 | 1.58% up | 17% up | ||
| 14 | WatersWAT · Health Care | 28.9 | TRY 4.62T | TRY 23,520.48 | 3.63% up | 20% up | ||
| 15 | GlaukosGKOS · Health Care | 27.2 | TRY 696.3B | TRY 11,761.75 | 4.18% down | 152% up | ||
| 16 | Krystal BiotechKRYS · Health Care | 24.0 | TRY 471.6B | TRY 15,912.78 | 5.62% up | 46% up | ||
| 17 | HeartflowHTFL · Health Care | 22.9 | TRY 203.5B | TRY 2,315.71 | 2.51% down | 73% up | ||
| 18 | Ligand PharmaceuticalsLGND · Health Care | 22.3 | TRY 301.5B | TRY 15,073.59 | 1.67% up | 43% up | ||
| 19 | Ascendis PharmaASND · Health Care | 22.2 | TRY 894.8B | TRY 13,641.47 | 0.32% down | 28% up | ||
| 20 | Twist BioscienceTWST · Health Care | 21.1 | TRY 400.3B | TRY 5,871.29 | 3.88% up | 340% up | ||
| 21 | Guardant HealthGH · Health Care | 20.0 | TRY 990.8B | TRY 7,324.10 | 1.30% up | 44% up | ||
| 22 | Eli LillyLLY · Health Care | 18.9 | TRY 62.15T | TRY 69,776.75 | 2.32% down | 35% up | ||
| 23 | NateraNTRA · Health Care | 18.2 | TRY 2.12T | TRY 14,608.84 | 0.71% up | 32% up | ||
| 24 | Adaptive BiotechnologiesADPT · Health Care | 16.6 | TRY 232.5B | TRY 1,436.16 | 0.11% down | 88% up | ||
| 25 | Royalty PharmaRPRX · Health Care | 16.6 | TRY 1.99T | TRY 3,465.25 | 0.01% down | 78% up | ||
| 26 | TG TherapeuticsTGTX · Health Care | 16.2 | TRY 504.3B | TRY 3,336.57 | 5.44% up | 107% up | ||
| 27 | RepligenRGEN · Health Care | 15.0 | TRY 557B | TRY 8,713.33 | 6.47% up | 5% up | ||
| 28 | Intuitive SurgicalISRG · Health Care | 14.5 | TRY 7.36T | TRY 21,242.11 | 2.23% down | 24% down | ||
| 29 | BillionToOneBLLN · Health Care | 14.3 | TRY 220.7B | TRY 4,619.32 | 6.11% down | 0% up | ||
| 30 | argenxARGX · Health Care | 14.3 | TRY 2.99T | TRY 47,497.64 | 0.66% down | 4% up | ||
| 31 | IDEXX LaboratoriesIDXX · Health Care | 12.8 | TRY 2.78T | TRY 35,246.40 | 1.19% up | 1% down | ||
| 32 | 10x GenomicsTXG · Health Care | 11.7 | TRY 378.8B | TRY 2,879.88 | 1.37% up | 260% up | ||
| 33 | Mirum PharmaceuticalsMIRM · Health Care | 11.6 | TRY 304.7B | TRY 4,667.26 | 0.59% up | 31% up | ||
| 34 | Vertex PharmaceuticalsVRTX · Health Care | 11.3 | TRY 6.86T | TRY 27,070.50 | 0.42% up | 27% up | ||
| 35 | Axsome TherapeuticsAXSM · Health Care | 11.0 | TRY 355.7B | TRY 6,761.95 | 1.43% down | 7% down | ||
| 36 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 11.0 | TRY 376.9B | TRY 4,796.44 | 0.06% down | 126% up | ||
| 37 | Edwards LifesciencesEW · Health Care | 10.0 | TRY 3.05T | TRY 5,310.15 | 0.19% down | 23% up | ||
| 38 | Travere TherapeuticsTVTX · Health Care | 9.8 | TRY 243.4B | TRY 2,535.23 | 1.68% down | 44% up | ||
| 39 | Corcept TherapeuticsCORT · Health Care | 9.7 | TRY 374.4B | TRY 3,420.84 | 3.25% down | 8% down | ||
| 40 | Madrigal PharmaceuticalsMDGL · Health Care | 9.6 | TRY 466.6B | TRY 20,088.03 | 5.67% down | 24% down | ||
| 41 | Bio-TechneTECH · Health Care | 9.4 | TRY 576.7B | TRY 3,671.13 | 0.17% up | 26% up | ||
| 42 | West Pharmaceutical ServicesWST · Health Care | 9.2 | TRY 1.42T | TRY 20,387.78 | 2.44% down | 61% up | ||
| 43 | PenumbraPEN · Health Care | 9.0 | TRY 637.7B | TRY 16,178.21 | 0.47% up | 13% up | ||
| 44 | BeOne MedicinesONC · Health Care | 8.6 | TRY 2.33T | TRY 20,366.58 | 2.34% down | 17% up | ||
| 45 | Mettler-Toledo InternationalMTD · Health Care | 8.6 | TRY 1.74T | TRY 87,666.14 | 1.42% up | 22% up | ||
| 46 | GenmabGMAB · Health Care | 8.4 | TRY 1.59T | TRY 2,572.06 | 1.91% down | 70% up | ||
| 47 | AbbVieABBV · Health Care | 8.3 | TRY 25.51T | TRY 14,432.72 | 2.33% down | 26% up | ||
| 48 | Halozyme TherapeuticsHALO · Health Care | 7.8 | TRY 551.2B | TRY 4,834.29 | 0.18% down | 37% up | ||
| 49 | United TherapeuticsUTHR · Health Care | 7.7 | TRY 1.24T | TRY 29,133.90 | 1.16% down | 23% up | ||
| 50 | Arrowhead PharmaceuticalsARWR · Health Care | 7.3 | TRY 307.5B | TRY 2,175.43 | 0.28% up | 10% up | ||
| 51 | IlluminaILMN · Health Care | 7.3 | TRY 1.6T | TRY 10,597.59 | 3.65% up | 69% up | ||
| 52 | Agilent TechnologiesA · Health Care | 7.2 | TRY 2.52T | TRY 8,948.48 | 2.97% up | 19% up | ||
| 53 | ExelixisEXEL · Health Care | 7.2 | TRY 840.9B | TRY 3,446.07 | 0.31% down | 63% up | ||
| 54 | Medpace HoldingsMEDP · Health Care | 7.2 | TRY 913.1B | TRY 32,642.55 | 0.95% down | 10% up | ||
| 55 | Gilead SciencesGILD · Health Care | 7.1 | TRY 10.58T | TRY 8,527.12 | 0.75% down | 33% up | ||
| 56 | Johnson & JohnsonJNJ · Health Care | 7.0 | TRY 33.13T | TRY 13,761.07 | 2.15% down | 38% up | ||
| 57 | Caris Life SciencesCAI · Health Care | 6.9 | TRY 282.2B | TRY 984.01 | 2.21% down | 17% down | ||
| 58 | Regeneron PharmaceuticalsREGN · Health Care | 6.8 | TRY 4.94T | TRY 47,713.62 | 1.28% down | 36% up | ||
| 59 | DexComDXCM · Health Care | 6.6 | TRY 1.55T | TRY 4,164.15 | 0.59% up | 37% up | ||
| 60 | DanaherDHR · Health Care | 6.5 | TRY 8.11T | TRY 11,534.67 | 1.24% up | 2% up | ||
| 61 | AmgenAMGN · Health Care | 6.5 | TRY 12.12T | TRY 22,399.71 | 3.07% down | 34% up | ||
| 62 | BioNTechBNTX · Health Care | 6.5 | TRY 1.04T | TRY 4,201.49 | 1.89% down | 16% down | ||
| 63 | HealthEquityHQY · Health Care | 6.1 | TRY 406.2B | TRY 4,910.49 | 4.45% down | 2% down | ||
| 64 | ResMedRMD · Health Care | 6.0 | TRY 1.72T | TRY 12,242.66 | 2.00% up | 3% down | ||
| 65 | RevvityRVTY · Health Care | 6.0 | TRY 858.7B | TRY 7,691.97 | 3.14% up | 60% up | ||
| 66 | Neurocrine BiosciencesNBIX · Health Care | 5.8 | TRY 831.8B | TRY 8,218.29 | 1.84% down | 20% up | ||
| 67 | Thermo Fisher ScientificTMO · Health Care | 5.8 | TRY 12.95T | TRY 34,957.25 | 0.87% up | 20% up | ||
| 68 | Alnylam PharmaceuticalsALNY · Health Care | 5.4 | TRY 1.01T | TRY 7,539.07 | 4.54% down | 66% down | ||
| 69 | NovartisNVS · Health Care | 5.4 | TRY 14.79T | TRY 7,832.25 | 2.46% down | 25% up | ||
| 70 | AlkermesALKS · Health Care | 5.3 | TRY 397.3B | TRY 2,364.16 | 3.08% up | 58% up | ||
| 71 | Merck & CoMRK · Health Care | 5.2 | TRY 17.14T | TRY 6,952.70 | 3.90% down | 51% up | ||
| 72 | QiagenQGEN · Health Care | 4.9 | TRY 516.4B | TRY 2,500.91 | 0.38% down | 12% up | ||
| 73 | Ionis PharmaceuticalsIONS · Health Care | 4.8 | TRY 230.2B | TRY 1,382.16 | 1.59% up | 64% down | ||
| 74 | StrykerSYK · Health Care | 4.8 | TRY 6.11T | TRY 16,054.58 | 0.19% up | 13% down | ||
| 75 | AstraZenecaAZN · Health Care | 4.7 | TRY 13.99T | TRY 9,020.64 | 1.93% down | 2% up | ||
| 76 | IncyteINCY · Health Care | 4.7 | TRY 1.21T | TRY 5,944.46 | 1.08% down | 18% up | ||
| 77 | Lantheus HoldingsLNTH · Health Care | 4.3 | TRY 336.6B | TRY 5,147.15 | 0.20% up | 93% up | ||
| 78 | STERISSTE · Health Care | 4.2 | TRY 1.27T | TRY 13,098.50 | 0.84% up | 1% up | ||
| 79 | HaemoneticsHAE · Health Care | 4.2 | TRY 282.3B | TRY 6,199.80 | 1.60% up | 61% up | ||
| 80 | Abbott LaboratoriesABT · Health Care | 4.1 | TRY 9.13T | TRY 5,272.30 | 0.22% down | 17% down | ||
| 81 | Charles River Laboratories InternationalCRL · Health Care | 4.0 | TRY 805.8B | TRY 16,816.56 | 0.33% up | 105% up | ||
| 82 | Bio-Rad LaboratoriesBIO · Health Care | 3.9 | TRY 502.4B | TRY 18,679.63 | 3.34% up | 18% up | ||
| 83 | Novo NordiskNVO · Health Care | 3.8 | TRY 8.77T | TRY 1,989.73 | 3.12% down | 17% down | ||
| 84 | BiogenBIIB · Health Care | 3.8 | TRY 1.88T | TRY 12,686.73 | 0.25% up | 49% up | ||
| 85 | LivaNovaLIVN · Health Care | 3.8 | TRY 262.8B | TRY 4,770.71 | 2.85% up | 71% up | ||
| 86 | Jazz PharmaceuticalsJAZZ · Health Care | 3.7 | TRY 802.6B | TRY 12,503.04 | 2.93% up | 37% up | ||
| 87 | BioMarin PharmaceuticalBMRN · Health Care | 3.7 | TRY 600.4B | TRY 3,099.90 | 4.99% up | 11% up | ||
| 88 | LifeStance Health GroupLFST · Health Care | 3.7 | TRY 264.2B | TRY 694.87 | 2.82% down | 129% up | ||
| 89 | ZoetisZTS · Health Care | 3.7 | TRY 1.75T | TRY 4,318.06 | 2.50% up | 29% down | ||
| 90 | MSA SafetyMSA · Health Care | 3.6 | TRY 344.9B | TRY 8,954.54 | 2.67% up | 11% up | ||
| 91 | InsuletPODD · Health Care | 3.6 | TRY 490B | TRY 7,063.71 | 3.69% down | 58% down | ||
| 92 | MedtronicMDT · Health Care | 3.5 | TRY 6.5T | TRY 5,082.56 | 1.56% down | 2% up | ||
| 93 | Dr. Reddy's LaboratoriesRDY · Health Care | 3.5 | TRY 630.2B | TRY 755.93 | 1.28% up | 5% up | ||
| 94 | AlconALC · Health Care | 3.5 | TRY 1.82T | TRY 3,797.79 | 1.55% up | 2% down | ||
| 95 | Merit Medical SystemsMMSI · Health Care | 3.4 | TRY 259.8B | TRY 4,336.23 | 1.70% up | 1% up | ||
| 96 | TeleflexTFX · Health Care | 3.3 | TRY 331.9B | TRY 8,369.17 | 3.95% up | 51% up | ||
| 97 | Globus MedicalGMED · Health Care | 3.2 | TRY 471.5B | TRY 3,559.11 | 0.77% up | 16% down | ||
| 98 | Boston ScientificBSX · Health Care | 3.2 | TRY 3.19T | TRY 2,202.17 | 1.42% up | 56% down | ||
| 99 | Legend BiotechLEGN · Health Care | 3.1 | TRY 159.1B | TRY 820.01 | 0.87% up | 42% down | ||
| 100 | PTC TherapeuticsPTCT · Health Care | 2.9 | TRY 253.9B | TRY 3,039.34 | 0.22% down | 20% down |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. P/S divides today's market value by the latest fiscal year's revenue from the annual report. Sums are converted from US dollars at today's exchange rate (1 USD = 50.4623 TRY). 16 companies have no P/S ratio on file and are not ranked here.
Questions and answers
Which health care companies rank first by P/S ratio?
Roivant Sciences (3397), Dianthus Therapeutics (2323) and CG Oncology (1769) are the top three of the 154 health care companies ranked by P/S ratio as of 19 Nov 2026, 10:03 UTC.
How many health care companies are in this ranking?
154 are ranked by P/S ratio. 16 more have no P/S ratio on file and are left out rather than ranked at zero.
What are these health care companies worth together?
The 154 health care companies ranked by P/S ratio have a combined market value of TRY 458.96T as of 19 Nov 2026, 10:03 UTC.
What does ranking by P/S ratio measure?
Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.
Learn how this ranking works
All markets guides →- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Health care companies by P/S ratio”, data as of 19 November 2026. https://funkfolio.com/companies/sector/health-care?by=ps-ratio
Underlying data: Yahoo Finance; SEC EDGAR.